(Q33544035)

27 July 2017

title

Expanded-capacity adenoviral vectors--the helper-dependent vectors (English)

1 reference

27 July 2017

1 reference

Morsy MA

1

1 reference

27 July 2017

Caskey CT

series ordinal

2

1 reference

27 July 2017

publication date

1 January 1999

1 reference

Trends in Molecular Medicine

27 July 2017

published in

1 reference

27 July 2017

volume

5

1 reference

27 July 2017

issue

1

1 reference

27 July 2017

page(s)

18-24

1 reference

Adenovirus vaccines in the U.S. military

27 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2898%2901376-8

7 January 2021

A triploblast origin for Myxozoa?

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2898%2901376-8

7 January 2021

Advances in adenoviral vectors: from genetic engineering to their biology

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2898%2901376-8

7 January 2021

Isolation of a common receptor for Coxsackie B viruses and adenoviruses 2 and 5

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2898%2901376-8

7 January 2021

Molecular characterization of replication-competent variants of adenovirus vectors and genome modifications to prevent their occurrence

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2898%2901376-8

7 January 2021

Characteristics of a human cell line transformed by DNA from human adenovirus type 5

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2898%2901376-8

7 January 2021

MHC class I-restricted cytotoxic T lymphocytes to viral antigens destroy hepatocytes in mice infected with E1-deleted recombinant adenoviruses.

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2898%2901376-8

7 January 2021

Rescue, propagation, and partial purification of a helper virus-dependent adenovirus vector

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2898%2901376-8

7 January 2021

A helper-dependent adenovirus vector system: removal of helper virus by Cre-mediated excision of the viral packaging signal

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2898%2901376-8

7 January 2021

An adenoviral vector deleted for all viral coding sequences results in enhanced safety and extended expression of a leptin transgene

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2898%2901376-8

7 January 2021

In vivo expression of full-length human dystrophin from adenoviral vectors deleted of all viral genes

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2898%2901376-8

7 January 2021

Encapsidated adenovirus minichromosomes allow delivery and expression of a 14 kb dystrophin cDNA to muscle cells

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2898%2901376-8

7 January 2021

Adenoviral preterminal protein stabilizes mini-adenoviral genomes in vitro and in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2898%2901376-8

7 January 2021

Genomic DNA transfer with a high-capacity adenovirus vector results in improved in vivo gene expression and decreased toxicity.

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2898%2901376-8

7 January 2021

The structure and expression of two defective adenovirus 2/simian virus 40 hybrids

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2898%2901376-8

7 January 2021

Encapsidation of adenovirus 16 DNA is directed by a small DNA sequence at the left end of the genome

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2898%2901376-8

7 January 2021

Proof of recombination between viral and cellular genomes in human KB cells productively infected by adenovirus type 12: structure of the junction site in a symmetric recombinant (SYREC)

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2898%2901376-8

7 January 2021

Recombinant adenovirus deleted of all viral genes for gene therapy of cystic fibrosis

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2898%2901376-8

7 January 2021

A new adenoviral vector: Replacement of all viral coding sequences with 28 kb of DNA independently expressing both full-length dystrophin and beta-galactosidase

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2898%2901376-8

7 January 2021

Site-specific recombinases: tools for genome engineering.

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2898%2901376-8

7 January 2021

Covalently closed circles of human adenovirus DNA are infectious.

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2898%2901376-8

7 January 2021

Cellular and humoral immune responses to viral antigens create barriers to lung-directed gene therapy with recombinant adenoviruses

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2898%2901376-8

7 January 2021

Nondepleting anti-CD4 antibody treatment prolongs lung-directed E1-deleted adenovirus-mediated gene expression in rats

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2898%2901376-8

7 January 2021

"Sero-switch" adenovirus-mediated in vivo gene transfer: circumvention of anti-adenovirus humoral immune defenses against repeat adenovirus vector administration by changing the adenovirus serotype

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2898%2901376-8

7 January 2021

Oral tolerization to adenoviral antigens permits long-term gene expression using recombinant adenoviral vectors

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2898%2901376-8

7 January 2021

Immune responses to transgene-encoded proteins limit the stability of gene expression after injection of replication-defective adenovirus vectors

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2898%2901376-8

7 January 2021

Physiologically responsive gene therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2898%2901376-8

7 January 2021

10.1016/S1357-4310(98)01376-8

Identifiers

DOI

1 reference

27 July 2017

1 reference